Table of Content

Table of Contents

Global Active Pharmaceutical Ingredient Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
1 Market Scope
1.1 Product Details and Introduction
1.1.1 Synthetic API -Product Introduction and Major Manufacturers
1.1.2 Biotech API -Product Introduction and Major Manufacturers
1.1.3 Other -Product Introduction and Major Manufacturers
1.2 Market Snapshot
1.2.1 Major Companies Overview
1.2.2 Market Concentration
1.2.3 Six-Year Compound Annual Growth Rate (CAGR)
2 Regional Market Analysis
2.1 China Active Pharmaceutical Ingredient Status and Prospect (2015-2026)
2.1.1 China Active Pharmaceutical Ingredient Market Size and Growth Rate (2015-2026)
2.1.2 China Active Pharmaceutical Ingredient Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.2 EU Active Pharmaceutical Ingredient Status and Prospect (2015-2026)
2.2.1 EU Active Pharmaceutical Ingredient Market Size and Growth Rate (2015-2026)
2.2.2 EU Active Pharmaceutical Ingredient Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.3 USA Active Pharmaceutical Ingredient Status and Prospect (2015-2026)
2.3.1 USA Active Pharmaceutical Ingredient Market Size and Growth Rate (2015-2026)
2.3.2 USA Active Pharmaceutical Ingredient Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.4 Japan Active Pharmaceutical Ingredient Status and Prospect (2015-2026)
2.4.1 Japan Active Pharmaceutical Ingredient Market Size and Growth Rate (2015-2026)
2.4.2 Japan Active Pharmaceutical Ingredient Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.5 India Active Pharmaceutical Ingredient Status and Prospect (2015-2026)
2.5.1 India Active Pharmaceutical Ingredient Market Size and Growth Rate (2015-2026)
2.5.2 India Active Pharmaceutical Ingredient Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.6 Southeast Asia Active Pharmaceutical Ingredient Status and Prospect (2015-2026)
2.6.1 Southeast Asia Active Pharmaceutical Ingredient Market Size and Growth Rate (2015-2026)
2.6.2 Southeast Asia Active Pharmaceutical Ingredient Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.7 South America Active Pharmaceutical Ingredient Status and Prospect (2015-2026)
2.7.1 South America Active Pharmaceutical Ingredient Market Size and Growth Rate (2015-2026)
2.7.2 South America Active Pharmaceutical Ingredient Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.8 Active Pharmaceutical Ingredient Status and Prospect (2015-2026)
2.8.1 Active Pharmaceutical Ingredient Market Size and Growth Rate (2015-2026)
2.8.2 Active Pharmaceutical Ingredient Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
3 Global Active Pharmaceutical Ingredient Market Assessment by Segment
3.1 Global Active Pharmaceutical Ingredient Capacity and Growth Rate
3.2 Global Active Pharmaceutical Ingredient Sales by Type
3.3 Global Active Pharmaceutical Ingredient Sales Revenue by Type
3.4 Global Active Pharmaceutical Ingredient Consumption by Application
4 Global Active Pharmaceutical Ingredient Market Assessment by Regions
4.1 Global Active Pharmaceutical Ingredient Production Analysis and Forecast by Regions (2015-2026)
4.2 Global Active Pharmaceutical Ingredient Sales Analysis and Forecast by Regions (2015-2026)
4.3 Global Active Pharmaceutical Ingredient Sales Revenue Analysis and Forecast by Regions (2015-2026)
5 Value Chain (Impact of COVID-19)
5.1 Active Pharmaceutical Ingredient Value Chain Analysis
5.1.1 Upstream
5.1.2 Downstream
5.2 COVID-19 Impact on Active Pharmaceutical Ingredient Industry
5.2.1 Industrial Policy Issued Under the Epidemic Situation
5.3 Cost-Under the Epidemic Situation
5.3.1 Cost of Raw Material
5.4 Channel Analysis
5.4.1 Distribution Channel-Under the Epidemic Situation
5.4.2 Distributors
6 Competitive Landscape
6.1 Global Active Pharmaceutical Ingredient Capacity Market Share of Manufacturers (2019-2020)
6.2 Global Active Pharmaceutical Ingredient Sales Market Share of Manufacturers (2019-2020)
6.3 Global Active Pharmaceutical Ingredient Sales Revenue Market Share of Manufacturers (2019-2020)

7 Active Pharmaceutical Ingredient Competitive Analysis
7.1 Teva
7.1.1 Teva Company Profiles
7.1.2 Teva Product Introduction
7.1.3 Teva Active Pharmaceutical Ingredient Production, Revenue (2015-2020)
7.1.4 SWOT Analysis
7.2 Novartis
7.2.1 Novartis Company Profiles
7.2.2 Novartis Product Introduction
7.2.3 Novartis Active Pharmaceutical Ingredient Production, Revenue (2015-2020)
7.2.4 SWOT Analysis
7.3 Pfizer
7.3.1 Pfizer Company Profiles
7.3.2 Pfizer Product Introduction
7.3.3 Pfizer Active Pharmaceutical Ingredient Production, Revenue (2015-2020)
7.3.4 SWOT Analysis
7.4 Johnson & Johnson
7.4.1 Johnson & Johnson Company Profiles
7.4.2 Johnson & Johnson Product Introduction
7.4.3 Johnson & Johnson Active Pharmaceutical Ingredient Production, Revenue (2015-2020)
7.4.4 SWOT Analysis
7.5 Mylan
7.5.1 Mylan Company Profiles
7.5.2 Mylan Product Introduction
7.5.3 Mylan Active Pharmaceutical Ingredient Production, Revenue (2015-2020)
7.5.4 SWOT Analysis
7.6 North China Pharmaceutical Group
7.6.1 North China Pharmaceutical Group Company Profiles
7.6.2 North China Pharmaceutical Group Product Introduction
7.6.3 North China Pharmaceutical Group Active Pharmaceutical Ingredient Production, Revenue (2015-2020)
7.6.4 SWOT Analysis
7.7 Dr. Reddy's Laboratories
7.7.1 Dr. Reddy's Laboratories Company Profiles
7.7.2 Dr. Reddy's Laboratories Product Introduction
7.7.3 Dr. Reddy's Laboratories Active Pharmaceutical Ingredient Production, Revenue (2015-2020)
7.7.4 SWOT Analysis
7.8 Roche
7.8.1 Roche Company Profiles
7.8.2 Roche Product Introduction
7.8.3 Roche Active Pharmaceutical Ingredient Production, Revenue (2015-2020)
7.8.4 SWOT Analysis
7.9 Aurobindo pharma
7.9.1 Aurobindo pharma Company Profiles
7.9.2 Aurobindo pharma Product Introduction
7.9.3 Aurobindo pharma Active Pharmaceutical Ingredient Production, Revenue (2015-2020)
7.9.4 SWOT Analysis
7.10 Sun Pharmaceutical Industries
7.10.1 Sun Pharmaceutical Industries Company Profiles
7.10.2 Sun Pharmaceutical Industries Product Introduction
7.10.3 Sun Pharmaceutical Industries Active Pharmaceutical Ingredient Production, Revenue (2015-2020)
7.10.4 SWOT Analysis
7.11 Boehringer Ingelheim GmbH
7.12 Bayer
7.13 BASF
7.14 DSM
7.15 Zhejiang Medicine
7.16 Biocon
7.17 Johnson Matthey
7.18 Hisun Pharmacy
7.19 Cambrex
7.20 Shandong Xinhua Pharmaceutical
7.21 Lonza group
7.22 Huahai Pharmaceutical
7.23 Haerbin Pharmaceutical Group
7.24 Cipla
7.25 Tian Yao
7.26 Lupin
7.27 North East Pharmaceutical
7.28 Albemarle
7.29 Shandong Lukang Pharmaceutical
7.30 Jiangsu　Hengrui Medicine
8 Conclusion

List of Figure

List of Tables and Figures

Figure Product Introduction
Table Production (K Units) and Revenue (Million USD) of Major Players (2015-2020)
Figure Global Active Pharmaceutical Ingredient Production Market Share of Top 5 Players
Table CAGR of Major Market (2021-2026)
Table CAGR in Terms of Production of Each Type (2015-2026)
Table CAGR in Terms of Production of Each Application (2015-2026)
Table Global Active Pharmaceutical Ingredient Sales (K Unit) by Type (2015-2026)
Figure Global Active Pharmaceutical Ingredient Sales (K Unit) and Growth Rate (2015-2026)
Figure Global Active Pharmaceutical Ingredient Sales Market Share (%) by Type (2019 -2020)
Table Global Active Pharmaceutical Ingredient Sales Value (Million USD) by Type (2015-2026)
Figure Global Active Pharmaceutical Ingredient Sales Value (Million USD) and Growth Rate (2015-2026)
Figure Global Active Pharmaceutical Ingredient Sales Value Market Share (%) by Type (2019-2020)
Table Global Active Pharmaceutical Ingredient Sales (K Unit) by Application (2015-2026)
Figure China Active Pharmaceutical Ingredient Production Value (Million USD) and Growth Rate (2015-2026)
Table China Active Pharmaceutical Ingredient Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure EU Active Pharmaceutical Ingredient Production Value (Million USD) and Growth Rate (2015-2026)
Table EU Active Pharmaceutical Ingredient Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure North America Active Pharmaceutical Ingredient Production Value (Million USD) and Growth Rate (2015-2026)
Table North America Active Pharmaceutical Ingredient Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure Japan Active Pharmaceutical Ingredient Production Value (Million USD) and Growth Rate (2015-2026)
Table Japan Active Pharmaceutical Ingredient Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure India Active Pharmaceutical Ingredient Production Value (Million USD) and Growth Rate (2015-2026)
Table India Active Pharmaceutical Ingredient Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure Southeast Asia Active Pharmaceutical Ingredient Production Value (Million USD) and Growth Rate (2015-2026)
Table Southeast Asia Active Pharmaceutical Ingredient Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure South America Active Pharmaceutical Ingredient Production Value (Million USD) and Growth Rate (2015-2026)
Table South America Active Pharmaceutical Ingredient Local Capacity, Import, Export and Local Consumption (2015-2020)
Figure Middle East and Africa Active Pharmaceutical Ingredient Production Value (Million USD) and Growth Rate (2015-2026)
Table Middle East and Africa Active Pharmaceutical Ingredient Local Capacity, Import, Export and Local Consumption (2015-2020)
Table Global Active Pharmaceutical Ingredient Capacity (K Units) and Growth Rate (2015-2026)
Figure Global Active Pharmaceutical Ingredient Capacity (K Units) and Growth Rate (2015-2026)
Table Global Active Pharmaceutical Ingredient Sales (Unit) by Type (2015-2026)
Figure Global Active Pharmaceutical Ingredient Sales(Unit) and Growth Rate (2015-2026)
Table Sales Market Share (%) by Type (2019-2026)
Table Global Active Pharmaceutical Ingredient Sales Revenue (Million USD) by Type (2015-2026)
Figure Global Active Pharmaceutical Ingredient Sales Revenue (Million USD) and Growth Rate (2015-2026)
Table Sales Revenue Market Share (%) by Type (2019-2026)
Table Global Active Pharmaceutical Ingredient Consumption (Unit) by Application (2015-2026)
Figure Global Active Pharmaceutical Ingredient Consumption (Unit) and Growth Rate (2015-2026)
Table Consumption Market Share (%) by Application (2019-2026)
Table Global Active Pharmaceutical Ingredient Production (K Unite) by Regions (2015-2020)
Table Global Active Pharmaceutical Ingredient CAGR (%) in term of Production and Market Share by Regions (2015-2026)
Figure Global Active Pharmaceutical Ingredient Production Share by Regions (2019-2020)
Table Global Active Pharmaceutical Ingredient Sales (K Unite) by Regions (2015-2020)
Table Global Active Pharmaceutical Ingredient CAGR (%) in term of Sales and Market Share by Regions (2015-2026)
Figure Global Active Pharmaceutical Ingredient Sales Share by Regions (2019-2020)
Table Global Active Pharmaceutical Ingredient Sales Revenue (Million USD) by Regions (2015-2020)
Table Global Active Pharmaceutical Ingredient CAGR (%) in term of Sales Revenue and Market Share by Regions (2015-2026)
Figure Global Active Pharmaceutical Ingredient Sales Revenue Share by Regions (2019-2020)
Figure Value Chain Structure of Active Pharmaceutical Ingredient
Table Value Chain
Table Key Suppliers of Raw Material/Components
Table Key Downstream Customer in Each Application Field
Table Industry News List of Active Pharmaceutical Ingredient
Figure Cost Structure of Active Pharmaceutical Ingredient in 2020
Table Global Active Pharmaceutical Ingredient Capacity Share of Manufacturers (2019-2020)
Figure Global Active Pharmaceutical Ingredient Capacity Share of Manufacturers (2019-2020)
Table Global Active Pharmaceutical Ingredient Sales Market Share of Manufacturers (2019-2020)
Figure Global Active Pharmaceutical Ingredient Sales Market Share of Manufacturers (2019-2020)
Table Global Active Pharmaceutical Ingredient Sales Revenue Market Share of Manufacturers (2019-2020)
Figure Global Active Pharmaceutical Ingredient Sales Revenue Market Share of Manufacturers (2019-2020)
Figure Global Active Pharmaceutical Ingredient Sales Value (Million USD), Growth Rate & Market Share (2021-2026)
Table ?Teva Profiles
Table ?Teva Active Pharmaceutical Ingredient Product Introduction
Table ?Teva Active Pharmaceutical Ingredient Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ?Teva SWOT Analysis
Table ????Novartis Profiles
Table ????Novartis Active Pharmaceutical Ingredient Product Introduction
Table ????Novartis Active Pharmaceutical Ingredient Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Novartis SWOT Analysis
Table ????Pfizer Profiles
Table ????Pfizer Active Pharmaceutical Ingredient Product Introduction
Table ????Pfizer Active Pharmaceutical Ingredient Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Pfizer SWOT Analysis
Table ????Johnson & Johnson Profiles
Table ????Johnson & Johnson Active Pharmaceutical Ingredient Product Introduction
Table ????Johnson & Johnson Active Pharmaceutical Ingredient Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Johnson & Johnson SWOT Analysis
Table ????Mylan Profiles
Table ????Mylan Active Pharmaceutical Ingredient Product Introduction
Table ????Mylan Active Pharmaceutical Ingredient Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Mylan SWOT Analysis
Table ????North China Pharmaceutical Group Profiles
Table ????North China Pharmaceutical Group Active Pharmaceutical Ingredient Product Introduction
Table ????North China Pharmaceutical Group Active Pharmaceutical Ingredient Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????North China Pharmaceutical Group SWOT Analysis
Table ????Dr. Reddy's Laboratories Profiles
Table ????Dr. Reddy's Laboratories Active Pharmaceutical Ingredient Product Introduction
Table ????Dr. Reddy's Laboratories Active Pharmaceutical Ingredient Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Dr. Reddy's Laboratories SWOT Analysis
Table ????Roche Profiles
Table ????Roche Active Pharmaceutical Ingredient Product Introduction
Table ????Roche Active Pharmaceutical Ingredient Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Roche SWOT Analysis
Table ????Aurobindo pharma Profiles
Table ????Aurobindo pharma Active Pharmaceutical Ingredient Product Introduction
Table ????Aurobindo pharma Active Pharmaceutical Ingredient Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Aurobindo pharma SWOT Analysis
Table ????Sun Pharmaceutical Industries Profiles
Table ????Sun Pharmaceutical Industries Active Pharmaceutical Ingredient Product Introduction
Table ????Sun Pharmaceutical Industries Active Pharmaceutical Ingredient Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Sun Pharmaceutical Industries SWOT Analysis
Table ????Boehringer Ingelheim GmbH Profiles
Table ????Boehringer Ingelheim GmbH Active Pharmaceutical Ingredient Product Introduction
Table ????Boehringer Ingelheim GmbH Active Pharmaceutical Ingredient Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Boehringer Ingelheim GmbH SWOT Analysis
Table ????Bayer Profiles
Table ????Bayer Active Pharmaceutical Ingredient Product Introduction
Table ????Bayer Active Pharmaceutical Ingredient Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Bayer SWOT Analysis
Table ????BASF Profiles
Table ????BASF Active Pharmaceutical Ingredient Product Introduction
Table ????BASF Active Pharmaceutical Ingredient Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????BASF SWOT Analysis
Table ????DSM Profiles
Table ????DSM Active Pharmaceutical Ingredient Product Introduction
Table ????DSM Active Pharmaceutical Ingredient Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????DSM SWOT Analysis
Table ????Zhejiang Medicine Profiles
Table ????Zhejiang Medicine Active Pharmaceutical Ingredient Product Introduction
Table ????Zhejiang Medicine Active Pharmaceutical Ingredient Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Zhejiang Medicine SWOT Analysis
Table ????Biocon Profiles
Table ????Biocon Active Pharmaceutical Ingredient Product Introduction
Table ????Biocon Active Pharmaceutical Ingredient Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Biocon SWOT Analysis
Table ????Johnson Matthey Profiles
Table ????Johnson Matthey Active Pharmaceutical Ingredient Product Introduction
Table ????Johnson Matthey Active Pharmaceutical Ingredient Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Johnson Matthey SWOT Analysis
Table ????Hisun Pharmacy Profiles
Table ????Hisun Pharmacy Active Pharmaceutical Ingredient Product Introduction
Table ????Hisun Pharmacy Active Pharmaceutical Ingredient Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Hisun Pharmacy SWOT Analysis
Table ????Cambrex Profiles
Table ????Cambrex Active Pharmaceutical Ingredient Product Introduction
Table ????Cambrex Active Pharmaceutical Ingredient Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Cambrex SWOT Analysis
Table ????Shandong Xinhua Pharmaceutical Profiles
Table ????Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredient Product Introduction
Table ????Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredient Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Shandong Xinhua Pharmaceutical SWOT Analysis
Table ????Lonza group Profiles
Table ????Lonza group Active Pharmaceutical Ingredient Product Introduction
Table ????Lonza group Active Pharmaceutical Ingredient Capacity (K Unit), Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Figure ????Lonza group SWOT Analysis
Table ????Huahai Pharmaceutical Profiles
Table ????Haerbin Pharmaceutical Group Profiles
Table ????Cipla Profiles
Table ????Tian Yao Profiles
Table ????Lupin Profiles
Table ????North East Pharmaceutical Profiles
Table ????Albemarle Profiles
Table ????Shandong Lukang Pharmaceutical Profiles
Table ????Jiangsu　Hengrui Medicine Profiles